Study to assess CSL787 in non-cystic fibrosis bronchiectasis (NCFB)

Trial Identifier:	CSL787_1001
Sponsor:	CSL Behring
Start Date:	December 2020
Primary Completion Date:	March 2023
Study Completion Date:	March 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Frankfurt, Germany
United Kingdom, England	Manchester, England, United Kingdom, M23 9QZ
United Kingdom, Northern Ireland	Belfast, Northern Ireland, United Kingdom, BT9 6AD

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.